Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

97.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.7K
Sanger Sequencing01:57

Sanger Sequencing

773.0K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
773.0K
Genomic DNA in Eukaryotes00:58

Genomic DNA in Eukaryotes

52.2K
Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.
52.2K
DNA Isolation01:24

DNA Isolation

44.4K
DNA isolation protocols can be fast and straightforward or complex and time-consuming depending on the type and quality of DNA required for further processing. For example, plasmid DNA extraction is a bit more complicated than genomic DNA extraction because of the need for an appropriate lysis method to separate plasmid DNA from gDNA during isolation. However, for specific applications, such as long-range DNA sequencing that require a good yield of high- quality DNA samples, we need to follow...
44.4K
DNA Isolation01:34

DNA Isolation

198.9K
DNA from cells is required for many biotechnology and research applications, such as molecular cloning. To remove and purify DNA from cells, researchers use various methods of DNA extraction. While the specifics of different protocols may vary, some general concepts underlie the process of DNA extraction.
198.9K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis.

NEJM evidence·2026
Same author

Holistic determination of ends of cfDNA molecules.

Cell genomics·2026
Same author

Checking Up on the King of Cancers.

Cancer discovery·2026
Same author

Clinical Variables and Cell-Free DNA Fragmentomics: Biological and Clinical Insights.

Clinical chemistry·2026
Same author

Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.

American journal of human genetics·2025
Same author

The comings and goings of cell-free DNA: Biological and clinical implications.

Med (New York, N.Y.)·2025
Same journal

AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.

Med (New York, N.Y.)·2026
Same journal

Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation.

Med (New York, N.Y.)·2026
Same journal

Atlas of human brain imaging-derived phenotypes and disease risk.

Med (New York, N.Y.)·2026
Same journal

Withdrawal effects following treatment discontinuation: A blind spot in evidence-based medicine.

Med (New York, N.Y.)·2026
Same journal

Rethinking parenteral nutrition as supportive therapy for neonatal sepsis.

Med (New York, N.Y.)·2026
Same journal

Power and sample-size estimation in human microbiome research.

Med (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.7K

Cell-free DNA in 2030.

W H Adrian Tsui1, Y M Dennis Lo2

  • 1Centre for Novostics, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong SAR, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China; Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.

Med (New York, N.Y.)
|January 10, 2026
PubMed
Summary
This summary is machine-generated.

Cell-free DNA (cfDNA) analysis advances liquid biopsies. Recent progress in cfDNA biology, lab techniques, and clinical data offers promising future applications in this minimally invasive field.

More Related Videos

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

14.2K
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.5K

Related Experiment Videos

Last Updated: Jan 13, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.7K
Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

14.2K
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.5K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genomics

Background:

  • Cell-free DNA (cfDNA) analysis is crucial for minimally invasive liquid biopsies.
  • Significant progress has been made in understanding cfDNA biology over the past five years.
  • The field has seen innovations in both laboratory (wet-lab) and data analysis (dry-lab) methodologies.

Purpose of the Study:

  • To summarize key advancements in cfDNA analysis over the last five years.
  • To discuss the future prospects of cfDNA in liquid biopsies for the next five years.
  • To highlight innovations in cfDNA biology, wet-lab, and dry-lab approaches.

Main Methods:

  • Review of recent literature on cfDNA analysis.
  • Synthesis of findings related to cfDNA biology.
  • Analysis of innovations in experimental and computational techniques.
  • Examination of accumulated clinical outcome data.

Main Results:

  • Deepened understanding of fundamental cfDNA biology.
  • Development of novel wet-lab and dry-lab techniques for cfDNA analysis.
  • Accumulation of substantial clinical outcome data associated with cfDNA analysis.
  • Identification of key areas for future research and development.

Conclusions:

  • cfDNA analysis has significantly matured as a core component of liquid biopsies.
  • Innovations in methodology and biological understanding pave the way for expanded clinical utility.
  • The field is poised for continued growth and application in diagnostics and prognostics.